http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a9cc3e5e1f12eceae45e03627ea9ff5
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Baker |
| name | Andrew H. Baker Andrew H Baker |
| given-name | Andrew H Andrew H. |
| organization-name | From the British Heart Foundation Glasgow Cardiovascular Research Centre (R.M., S.A.N., M.A.C., M.M., K.G., D.G., A.F.D., A.H.B.), Glasgow, United Kingdom; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centre (P.G., J.M.A., J.S.C.), University of Washington, Seattle; Faculty of Biological and Life Science (G.S.), University of Glasgow, Glasgow, United Kingdom; Sbarro Institute for Cancer Research and Molecular Medicine (C.N.), Temple University, Philadelphia, Pa; and the... Centre for Cardiovascular Science, Queens Medical Research Institute, University of Edinburgh , Edinburgh EH16 4TJ , UK; CARIM School for Cardiovascular Diseases, Maastricht University , Maastricht 6229ER , The Netherlands Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow United Kingdom From the Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy (P.M., A.I.); Division of Immunology, Infection & Inflammation (P.M., I.B.M.) and BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (A.H.B.); and Centre for Biophotonics (B.H.Z., J.M.B., P.G.) and Department of Physiology and Pharmacology (S.K.), Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom. From the Bristol Heart Institute, University of Bristol, Bristol, UK. Dr Baker’s current address is Dept of Medicine and Therapeutics, University of Glasgow, Western Infirmary, Glasgow G116NT, UK. From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.C., Y.D., H.C.S., R.A.M., R.L., K.W., K.M.M., J.D.M., M.R.M., A.H.B.); the Division of Respiratory Medicine, Department of Medicine, Addenbrooke's Hospital, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom (P.C., L.L., M.S., P.U., N.W.M.); the Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX (M.X., E.N.O.); and MiRagen... Present address: Centre for Cardiovascular Sciences, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.; Institute of Cardiovascular and Medical Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK BHF Blood Pressure Group, Department of Medicine and Therapeutics, University of Glasgow, Western Infirmary, Glasgow G11 6NT, Scotland From the Institute for General and Experimental Pathology, University of Innsbruck Medical School (Y.H.), and the Institute for Biomedical Aging Research, Austrian Academy of Sciences (Y.Z., Q.X.), Innsbruck, Austria; the Bristol Heart Institute (A.H.B., A.C.N.), Bristol, UK; and the Department of Cardiological Sciences, St George’s Hospital Medical School (Q.X.), London, UK. Department of Pathology, School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, The Netherlands. Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh , Edinburgh EH16 4TJ , UK British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom. British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; From the British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom; Imperial College London, Gene Therapy Research Group, United Kingdom; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle; and Haemostasis and Thrombosis, Medical Research Council (MRC) Clinical Sciences Centre, Imperial College London, United Kingdom. Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom From the Queens Medical Research Institute, BHF Centre for Cardiovascular Sciences, University of Edinburgh, United Kingdom (A.D.M., M.D.B., V.M., K.P., J.H., J.P.S., J.I., J.K., A.S.T., N.L.M., D.E.N., A.C., J.C.S., J.R., A.H.B.); Department of Pathology, Maastricht University Medical Center, the Netherlands (J.C.S., A.H.B.). From Bristol Heart Institute (S.J.W.), Bristol Royal Infirmary, University of Bristol (UK); the Department of Medicine and Therapeutics (S.A.N., A.H.B.), University of Glasgow (UK); and the Department of Bioscience (T.S.), National Cardiovascular Center Research Institute, Osaka, Japan. From the Bristol Heart Institute (S.J.G., J.L.J., J.L.S.), University of Bristol, Bristol, United Kingdom; the Division of Cardiothoracic Surgery (S.W., J.H.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China; and the Institute of Cardiovascular and Medical Sciences (R.M., A.H.B.), University of Glasgow, Glasgow, United Kingdom. British Heart Foundation Glasgow Cardiovascular Research Centre, Division of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, United Kingdom Glasgow Cardiovascular Research Centre, Faculty of Medicine, University of Glasgow, Glasgow G12 8QQ, U.K. From the Department of Medicine and Therapeutics, University of Glasgow, Western Infirmary (S.A.N., M.J.B., A.F.D., A.H.B.), Glasgow, United Kingdom; The Gene Therapy Center at the University of Alabama at Birmingham (P.N.R., D.T.C.); and Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary (S.J.W.), Bristol, United Kingdom. From the Bristol Heart Institute, University of Bristol (S.A.N., S.J.W., A.H.B.), and the Paterson Institute for Cancer Research, University of Manchester (S.J.W., R.E.H.), UK. Drs Nicklin and Baker are now at the Department of Medicine and Therapeutics, University of Glasgow, Western Infirmary, UK. The first 2 authors contributed equally to this article. Centre for Cardiovascular Sciences, Little France Crescent, University of Edinburgh, Edinburgh, United Kingdom. British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, United Kingdom. Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom; and University of Glasgow, Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK ; ; Glasgow Cardiovascular Research Centre, Faculty of Medicine, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K. British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow G12 8TA, United Kingdom. Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom; Centre for Cardiovascular Sciences, Queen’s Medical Research Institute, Edinburgh, UK From BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (M.D.B., R.D., L.D., R.M., R.G., P.W., N.S., M.W.N., R.A.M., A.H.B.); British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science, Edinburgh, United Kingdom (M.D.B., K.P., A.T.V., N.J., M.R.D., D.E.N., R.A.M., A.H.B.); Glasgow Polyomics, College of Medical, Veterinary and Life Sciences, The University of Glasgow, United Kingdom (G.H.); and Aab Cardiovascular Research Institute, University of... Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, United Kingdom (L.D., J.R., A.H.B.) Centre for Cardiovascular Sciences, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, UK BHF Blood Pressure Group, Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, UK From the Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy (A.I., G.G., M.M., M.V.D.L., P.M.); Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom (P.G.); Institute of Infection, Immunity and Inflammation (P.G., P.M.) and Institute of Cardiovascular and Medical Sciences (A.H.B., S.K.), College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom; Angelini R&D,... Centre for Cardiovascular Science, Queen's Medical Research Institute, BHF/University of Edinburgh, Edinburgh, UK From INSERM U492 (A.V.-B., E.F., S.E., I.D., M.L., B.R., S.A., M.-P.d’O.), Faculté de Médecine, Créteil, France; Service de Réanimation Médicale (A.V.-B.) and Service des Explorations Fonctionnelles (B.R.), Hôpital Ambroise Paré, AP-HP, Boulogne, France; Bristol Heart Institute (A.H.B., A.C.N.), University of Bristol, Bristol Royal Infirmary, Bristol, UK; INSERM E-9937 (P.B.), Université Victor Segalen Bordeaux 2, Bordeaux, France; and Service des Explorations Fonctionnelles (S.A., M.-P.d’O.... *British Heart Foundation Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, United Kingdom; Department of Medicine and Therapeutics, University of Glasgow British Heart Foundation Glasgow Cardiovascular Research Centre, Division of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow G12 8TA, United Kingdom Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, United Kingdom. the Bristol Heart Institute (K.M.S., A.H.B., A.C.N.), University of Bristol, Bristol (UK) Royal Infirmary, and the Departments of Pharmacology (M.F.) and Cardiology (A.P.B., V.J.T., R.P.F., P.H.G.) and the Institute of Nephrology (M.D.), University of Wales College of Medicine, Heath Park Cardiff. Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom Centre for Cardiovascular Science Queen's Medical Research Institute, University of Edinburgh Edinburgh UK Division of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow From the British Heart Foundation Glasgow Cardiovascular Research Centre (N.M.K., H.L.S., M.A.C., and A.H.B.), Faculty of Medicine, University of Glasgow, Glasgow, Scotland; Neuroscience and Molecular Pharmacology (N.M.K., G.M., M.D.H., and J.C.M.), Faculty of Biomedical and Life Sciences, University of Glasgow; Experimental Cardiovascular Medicine Division (M.M. and C.E.), Bristol Heart Institute, University of Bristol, Bristol, England; and Cellartis AB (R.S.), Dundee, Scotland. Department of Medicine and Therapeutics, University of Glasgow, G14ORP Glasgow, United Kingdom From the Bristol Heart Institute (J.L.J., A.C.N., C.L.J., S.J.G.), University of Bristol, Bristol, England; the British Heart Foundation Glasgow Cardiovascular Research Centre (A.H.B.), Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland; and the Departments of Medicine and Molecular and Cellular Biology (K.O., L.C.), Baylor College of Medicine, Houston, Tex. From the Regenerative Medicine (A.C., M.M., R.A., P.M., C.E.) and Vascular Biology (G.B.S.-N.) sections, School of Clinical Science, University of Bristol, Bristol, UK; IRCCS-Policlinico San Donato, Milan, Italy (C.V.), Italian Higher Institute of Health, Rome, Italy (D.B.); IRCCS-MultiMedica, Milan, Italy (G.S., S.L., G.C.); British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK (R.M., A.H.B.); Netherlands Cancer Institute, Amsterdam, the Netherlands (R... Centre for Cardiovascular Science; Department of Pathology, CARIM School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, The Netherlands From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK. British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom Department of Medicine and Therapeutics, Division of Cardiovascular and Medical Sciences, University of Glasgow From the Centre for Cardiovascular Science, University of Edinburgh, United Kingdom (J.H., J.P.S., A.D.M., J.R., M.B., J.K., K.L.C., R.B., D.E.N., J.C.S., A.H.B.); Maastricht University Medical Center, Maastricht, the Netherlands (M.A.C.F., L.T., E.A.L.B., J.C.S., A.H.B.). British Heart Foundation/University of Edinburgh, Centre for Cardiovascular Science, Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh, UK Glasgow Cardiovascular Research Centre, Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, United Kingdom From Microvascular Research Laboratories, Bristol Heart Institute, Department of Physiology (A.V.B., O.A.S., S.J.H., D.O.B.) and Laboratories for Integrative Neuroscience and Endocrinology (C.P.G., J.B.U.), University of Bristol, and BHF Glasgow Cardiovascular Research Centre (W.H.M., A.H.B.), University of Glasgow, UK. Present address for A.V.B.: Division of Vascular Oncology and Metastasis A190, DKFZ, Im Neuenheimer Feld 581 (TP4), D-69120 Heidelberg, Germany. From the Division of Cardiovascular and Medical Sciences, (P.C., J.M., R.A.M., J.A.G., K.E.R., R.M., L.D., and A.H.B.) British Heart Foundation Glasgow Cardiovascular Research Centre, Faculty of Medicine, Glasgow, Scotland; the (M.R.M. and Y.D.) Faculty of Biological and Life Sciences, University of Glasgow, Glasgow, Scotland; the Bioinformatics Core (R.K.), Computational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY; and the Department of Medicine (E.S., M.S., L.L., and N.W.M... From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (L.D., F.J.B., H.S., A.C., M.M., J.D.M., J.G., K.W., A.C.B., M.R.M., A.H.B.); Novartis Institutes for BioMedical Research, Horsham, United Kingdom (M.T.); Division of Critical Care Medicine/Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Medicine, University of Colorado Denver, Aurora (M.F., K.S.); MiRagen Therapeutics, Inc, Boulder, CO (A.G.S.); Division of... British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK 2British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, Scotland, UK British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK. From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (K.W., Y.D., P.C., E.W., R.A.M., H.S., M.R.M., A.H.B.); Solid Tumor Division, St. Jude Children’s Research Hospital, Memphis, TN (M.E.H.); MiRagen Therapeutics, Boulder, CO (E.V.R.); and Division of Respiratory Medicine, Addenbrooke’s Hospital, University of Cambridge, School of Clinical Medicine, Cambridge, United Kingdom (N.W.M.). From the Bristol Heart Institute, Bristol Royal Infirmary, Bristol (S.J.W., E.D.P.), and the Division of Cardiovascular and Medical Sciences, University of Glasgow (S.A.N., M.J.B., A.H.B.), UK; and the Laboratorium für Molekulare Biologie, Genzentrum, Ludwig-Maximilians Universität München (H.B., K.L., M.H.), the Medizinische Klinik III, Klinikum der Universität München (M.H.), and Gesellshaft für Strahelforschung (M.H.), Munich, Germany. Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow United Kingdom; Queens Medical Research Institute University of Edinburgh Edinburgh Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, G12 8TA United Kingdom. Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom. British Heart Foundation Glasgow Cardiovascular Research Centre, and Institute of Cardiovascular & Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow UK From Experimental and Molecular Cardiology (S.H., M.S., Y.M.P.), CARIM, Maastricht University, Maastricht, the Netherlands; Center of Transgene Technology and Gene Therapy, VIB (S.H., D.V., F.G., P.C.), Department of Cardiology (F.V.d.W.), and Rega Institute Laboratory of Virology (A.D.P., E.P., J.N.), University of Leuven, Leuven, Belgium; Department of Cardiology, Charité University Hospital (M.P., A.K.-O., S.R., R.T., H.-P.S.), Berlin, Germany; and BHF Blood Pressure Group (A.H.B.), Department... Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, UK CARIM School for Cardiovascular Diseases, Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. British Heart Foundation Glasgow Cardiovascular Research Center, College of Medical, Veterinary & Life Sciences, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK. British Heart Foundation Glasgow Cardiovascular Research Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow, 126 University Place, Glasgow G12 8TA, United Kingdom |
Incoming Links
Total number of triples: 367.